| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 T Vos, SS Lim, C Abbafati, KM Abbas, M Abbasi, M Abbasifard, ... The Lancet 396 (10258), 1204-1222, 2020 | 5768 | 2020 |
| Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ... Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008 | 5712 | 2008 |
| Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and … JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate, KH Abate, ... The Lancet 392 (10159), 1923-1994, 2018 | 5204* | 2018 |
| MDS clinical diagnostic criteria for Parkinson's disease RB Postuma, D Berg, M Stern, W Poewe, CW Olanow, W Oertel, J Obeso, ... Movement disorders 30 (12), 1591-1601, 2015 | 4993 | 2015 |
| Parkinson's disease LV Kalia, AE Lang The Lancet 386 (9996), 896-912, 2015 | 4908 | 2015 |
| Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The lancet 396 (10258), 1223-1249, 2020 | 4112 | 2020 |
| Parkinson disease W Poewe, K Seppi, CM Tanner, GM Halliday, P Brundin, J Volkmann, ... Nature reviews Disease primers 3 (1), 1-21, 2017 | 3826 | 2017 |
| Parkinson's disease AE Lang, AM Lozano New England Journal of Medicine 339 (16), 1130-1143, 1998 | 3692 | 1998 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 … HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1859-1922, 2018 | 3436 | 2018 |
| Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 MG Griswold, N Fullman, C Hawley, N Arian, SRM Zimsen, HD Tymeson, ... The Lancet 392 (10152), 1015-1035, 2018 | 2640 | 2018 |
| Phenomenology and classification of dystonia: a consensus update A Albanese, K Bhatia, SB Bressman, MR DeLong, S Fahn, VSC Fung, ... Movement disorders 28 (7), 863-873, 2013 | 2154 | 2013 |
| Levodopa and the progression of Parkinson's disease Parkinson Study Group New England Journal of Medicine 351 (24), 2498-2508, 2004 | 2149 | 2004 |
| Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease E Sidransky, MA Nalls, JO Aasly, J Aharon-Peretz, G Annesi, ER Barbosa, ... New England Journal of Medicine 361 (17), 1651-1661, 2009 | 2103 | 2009 |
| A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa O Rascol, DJ Brooks, AD Korczyn, PP De Deyn, CE Clarke, AE Lang New England Journal of Medicine 342 (20), 1484-1491, 2000 | 1944 | 2000 |
| Consensus statement on the diagnosis of multiple system atrophy S Gilman, P Low, N Quinn, A Albanese, Y Ben-Shlomo, C Fowler, ... Clinical autonomic research 8, 359-362, 1998 | 1878 | 1998 |
| Pharmacological treatment of Parkinson disease: a review BS Connolly, AE Lang Jama 311 (16), 1670-1683, 2014 | 1718 | 2014 |
| Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients D Weintraub, J Koester, MN Potenza, AD Siderowf, M Stacy, V Voon, ... Archives of neurology 67 (5), 589-595, 2010 | 1603 | 2010 |
| Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study DG Healy, M Falchi, SS O'Sullivan, V Bonifati, A Durr, S Bressman, ... The Lancet Neurology 7 (7), 583-590, 2008 | 1598 | 2008 |
| Criteria for the diagnosis of corticobasal degeneration MJ Armstrong, I Litvan, AE Lang, TH Bak, KP Bhatia, B Borroni, AL Boxer, ... Neurology 80 (5), 496-503, 2013 | 1534 | 2013 |
| Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ... Movement Disorders 32 (6), 853-864, 2017 | 1509 | 2017 |
